Home ProductsTestosterone Anabolic Steroid

250mg/ml 10ml Injectable Male Hormone Testosterone Enanthate CAS 315-37-7

Certification
Good quality Muscle Growth Hormone for sales
Your products is fantastic, I will buy more later

—— Michael

I'm Online Chat Now

250mg/ml 10ml Injectable Male Hormone Testosterone Enanthate CAS 315-37-7

China 250mg/ml 10ml Injectable Male Hormone Testosterone Enanthate CAS 315-37-7 supplier
250mg/ml 10ml Injectable Male Hormone Testosterone Enanthate CAS 315-37-7 supplier 250mg/ml 10ml Injectable Male Hormone Testosterone Enanthate CAS 315-37-7 supplier 250mg/ml 10ml Injectable Male Hormone Testosterone Enanthate CAS 315-37-7 supplier

Large Image :  250mg/ml 10ml Injectable Male Hormone Testosterone Enanthate CAS 315-37-7

Product Details:

Place of Origin: Hubei, China
Brand Name: Mking
Certification: ISO9001, SGS
Model Number: CAS 315-37-7

Payment & Shipping Terms:

Minimum Order Quantity: 10ml
Price: Negotiate
Packaging Details: As you required
Delivery Time: Within 24hours
Payment Terms: T/T, Western Union, MoneyGram
Supply Ability: 1000 vials per Month
Contact Now
Detailed Product Description
Alias: Test E EINECS: 206-253-5
Standard: USP Shipping: Reshipping
Packing: As You Required Whatsapp: +8613264710010
Description: Oil Function: Bodybuilding

250mg/ml 10ml Injectable Male Hormone Testosterone Enanthate CAS 315-37-7

 

Testosterone Enanthate Description

Testosterone Enanthate Injection, USP provides Testosterone Enanthate, USP, a derivative of the primary endogenous androgen testosterone, for intramuscular administration. In their active form, androgens have a 17-beta-hydroxy group. Esterification of the 17-beta-hydroxy group increases the duration of action of testosterone; hydrolysis to free testosterone occurs in vivo. Each mL of sterile, colorless to pale yellow, solution provides 200 mg Testosterone Enanthate, USP in sesame oil with 5 mg chlorobutanol (chloral derivative) as a preservative.

Testosterone Enanthate, USP is designated chemically as androst-4-en-3-one, 17-[(1-oxoheptyl)-oxy]-, (17β)-. Structural formula:

250mg/ml 10ml Injectable Male Hormone Testosterone Enanthate CAS 315-37-7

Testosterone Enanthate - Clinical Pharmacology

Endogenous androgens are responsible for the normal growth and development of the male sex organs and for maintenance of secondary sex characteristics. These effects include growth and maturation of prostate, seminal vesicles, penis, and scrotum; development of male hair distribution, such as beard, pubic, chest, and axillary hair; laryngeal enlargement; vocal chord thickening; alterations in body musculature; and fat distribution.

Androgens also cause retention of nitrogen, sodium, potassium, and phosphorus, and decreased urinary excretion of calcium. Androgens have been reported to increase protein anabolism and decrease protein catabolism. Nitrogen balance is improved only when there is sufficient intake of calories and protein.

Androgens are responsible for the growth spurt of adolescence and for the eventual termination of linear growth which is brought about by fusion of the epiphyseal growth centers. In children, exogenous androgens accelerate linear growth rates but may cause a disproportionate advancement in bone maturation. Use over long periods may result in fusion of the epiphyseal growth centers and termination of the growth process. Androgens have been reported to stimulate the production of red blood cells by enhancing the production of erythropoietic stimulating factor.

During exogenous administration of androgens, endogenous testosterone release is inhibited through feedback inhibition of pituitary luteinizing hormone (LH). At large doses of exogenous androgens, spermatogenesis may also be suppressed through feedback inhibition of pituitary follicle stimulating hormone (FSH).

There is a lack of substantial evidence that androgens are effective in fractures, surgery, convalescence, and functional uterine bleeding.

PHARMACOKINETICS

Testosterone esters are less polar than free testosterone. Testosterone esters in oil injected intramuscularly are absorbed slowly from the lipid phase; thus Testosterone Enanthate can be given at intervals of two to four weeks.

Testosterone in plasma is 98 percent bound to a specific testosterone-estradiol binding globulin, and about two percent is free. Generally, the amount of this sex-hormone binding globulin (SHBG) in the plasma will determine the distribution of testosterone between free and bound forms, and the free testosterone concentration will determine its half-life.

About 90 percent of a dose of testosterone is excreted in the urine as glucuronic and sulfuric acid conjugates of testosterone and its metabolites; about six percent of a dose is excreted in the feces, mostly in the unconjugated form. Inactivation of testosterone occurs primarily in the liver. Testosterone is metabolized to various 17-keto steroids through two different pathways. There are considerable variations of the half-life of testosterone as reported in the literature, ranging from 10 to 100 minutes.

In responsive tissues, the activity of testosterone appears to depend on reduction to dihydrotestosterone (DHT), which binds to cytosol receptor proteins. The steroid-receptor complex is transported to the nucleus where it initiates transcription events and cellular changes related to androgen action.

Indications and Usage for Testosterone Enanthate

Males

Testosterone Enanthate Injection, USP is indicated for replacement therapy in conditions associated with a deficiency or absence of endogenous testosterone.

Primary hypogonadism (congenital or acquired) – Testicular failure due to cryptorchidism, bilateral torsion, orchitis, vanishing testis syndrome, or orchidectomy.

Hypogonadotropic hypogonadism (congenital or acquired) – Gonadotropin or luteinizing hormone‑releasing hormone (LHRH) deficiency, or pituitary-hypothalamic injury from tumors, trauma, or radiation. (Appropriate adrenal cortical and thyroid hormone replacement therapy are still necessary, however, and are actually of primary importance.)

If the above conditions occur prior to puberty, androgen replacement therapy will be needed during the adolescent years for development of secondary sexual characteristics. Prolonged androgen treatment will be required to maintain sexual characteristics in these and other males who develop testosterone deficiency after puberty.

Safety and efficacy of Testosterone Enanthate Injection, USP in men with age-related hypogonadism have not been established.

Delayed puberty – Testosterone Enanthate Injection, USP may be used to stimulate puberty in carefully selected males with clearly delayed puberty. These patients usually have a familial pattern of delayed puberty that is not secondary to a pathological disorder; puberty is expected to occur spontaneously at a relatively late date. Brief treatment with conservative doses may occasionally be justified in these patients if they do not respond to psychological support. The potential adverse effect on bone maturation should be discussed with the patient and parents prior to androgen administration. An X-ray of the hand and wrist to determine bone age should be obtained every six months to assess the effect of treatment on the epiphyseal centers.

 

Steroid Powder List

 

Testosterone Base Boldenone Base MGF
Testosterone Acetate Boldenone Acetate PEG MGF
Testosterone Cypionate Equipoise CJC-1295
Testosterone Decanoate Boldenone Propionate CJC-1295 DAC
Testosterone Enanthate Boldenone Cypionate PT-141
Testosterone Isocaproate Nandrolone Base Melanotan-1
Testosterone Phenylpropionate Nandrolone Decanoate Melanotan-2
Testosterone Propionate Nandrolone phenylprop GHRP-2
Testosterone Undecanoate Nandrolone undecylate GHRP-6
Methyltestosterone Nandrolone cypionate Ipamorelin
Formestane Nandrolone propionate Hexarelin
Oral Turinabol Tibolone Sermorelin
Clostebol Acetate Trenbolone Base Oxytocin
Fluoxymesterone Trenbolone Acetate TB500
Testosterone Sustanon 250 Trenbolone Enanthate HGH 176-191
Mestanolone Methyltrienolone Triptorelin
Stanolone Trenbolone Hexa Tesamorelin
Mesterolone 7-keto DHEA Gonadorelin
Methenolone Enanthate DHEA DSIP
Methenolone Acetate Oxymetholone / Anadrol Selank
Methyldrostanolone Oxandrolone / Anavar BPC 157
Drostanolone Propionate Stanozolol / Winstrol Epitalon
Drostanolone Enanthate Methandienone / Dianabol Follistatin 344
Tamoxifen Citrate Sildenafil citrate MK-2866
Clomifene citrate Tadalafil / Cialis Andarine / S4
Toremifene citrate Vardenafil GW501516
Exemestane Avanafil RAD140
Anastrozole Dapoxetine SR9009
Letrozole Finasteride YK11
Androstadiendione Yohimbine HCL MK-677
Androstenedione Eplerenone LGD4033

 

 

Contact Details
Hubei Mking Biotech Co., Ltd.

Contact Person: sales

Send your inquiry directly to us (0 / 3000)